CCO Slideset

Managing Adverse Effects of the Treatment of Chronic HCV

Source: HCV and Methadone Maintenance

Managing Adverse Effects of the Treatment of Chronic HCV


Program Director: Diana L. Sylvestre, MD

Faculty:

  • Sherilyn C. Brinkley, MSN, CRNP

CME CREDIT INFORMATION

Release Date: 05/18/07

Expiration Date: 05/17/08


Physicians: maximum of 1.0 AMA PRA Category 1 Credit(s)™

Pharmacists: 1.0 contact hour (0.1 CEUs)

Registered Nurses: 1.0 Nursing CE credit

Status: Please log in to view status


Learning Objectives

Upon completion of this activity, participants should be able to:

  • Define commonly associated adverse events related to HCV therapy
  • Discuss strategies to manage these treatment-related adverse events in patients receiving methadone maintenance
  • Explain factors to consider when weighing pharmacologic and nonpharmacologic options for reducing adverse events
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Supported by an educational grant from

Educational grants support only the CME-certified components of this program.